Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump


Pfizer said it anticipates sales of its Covid treatment Paxlovid and its vaccine will be $9 billion less than it had expected…

Share post:



More like this

Gildan’s board abruptly resigns ahead of annual meeting, handing control to activist

Glenn Chamandy is returning to the apparel supplier he...

Jim Cramer warns against trading Nvidia after blowout quarter

CNBC's Jim Cramer on Thursday reminded investors he thinks...

SEC approves rule change to allow creation of ether ETFs

The regulator said it will allow exchanges to list...